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Abstract Introduction: Liver and kidney affection is a life-threatening disease 
caused by factors including drug-based treatment. Treatment based on 
methotrexate could result in liver and kidney damages. The study evaluates the 
preventive effects of Sorindeia juglandifolia leaves on methotrexate-induced liver 
and kidney impairment in rat. Methods: Healthy rats divided into 6 groups daily 
received distilled water, methotrexate (20 mg/kg), sub-cutaneous injection of L-
carnitin (500 mg/kg) and methotrexate and the plant extract doses of 150, 250 and 
350 mg/kg and methotrexate for 10 days. During treatment, body weight was 
recorded. At the end of the treatment, animals were sacrificed; venous blood were 
collected for haematological and biochemical analysis. Liver and kidney were 
collected for oxidative markers and histological examination. Results: The 
consecutive treatment of animals with plant extract and methotrexate showed a 
significant prevention of the body weight decrease and enhancement of the relative 
weight of liver and kidney. Sorindeia. juglandifolia extract also protected from the 
significant increase in transaminase activities, bilirubin and protein level, 
hypercholesterolemia, atherogenic index, and in the kidney from 
hypercreatininemia and the increase in serum urea level. The extract prevented the 
decrease of sodium level and glomerular filtration. Plant extract improved reactive 
oxygen species detoxification agents and protected from the histological 
disorganization of the liver and kidney tissues, observed in the MTX control. 
Conclusion: Sorindeia juglandifolia leaves extract expressed hepatorenal 
protective properties and could be useful to prevent liver and kidney damage 
induce by methotrexate. 
Keywords: Sorindeia juglandifolia, hepatorenal affection, methotrexate, 
preventive activities 
1. Introduction 
The liver and kidney affections are prevalent diseases affecting about 2 -7% people worldwide. An estimate of 40000 annual 
deaths could be due to liver failure [1] while kidney damage affects about 7.2% of people aged of about 30 years old and 
35.8% in individuals aged of more than 65 years over the world [2]. The physiological connectivity between liver and 
kidney is responsible for the activity of one to another. Thus, the toxicological susceptibility of liver and kidney is related 
to their physiological activities through biotransformation and excretion activities against xenobiotics [3]. The liver is 
implicated into biotransformation of xenobiotic products and the kidney ensures of their elimination. Indeed, the renal 
failure results in a reduction in clearance and tubular secretion leading to an increase of waste in the organism, responsible 
for exhaustion in the liver system. Likewise, the dysfunction of liver result in the detoxification failure that provoke a 
poisons accumulation in the organism and cause cellular damage especially in kidneys [4]. Hence, renal dysfunction is a 
common disease due either as part of multiorgan involvement in acute illness or secondary to advanced liver disease. 
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Furthermore, liver and kidneys are both implicated in the vitamin D production, blood pressure regulation through the 
renin-angiotensin system [5]. Liver and kidney affection could result from several factors including infectious diseases, 
toxins or drug exposure [6]. Twenty percent of kidney failure enamate from liver injury treatment [7] and 50 % of liver and 
kidneys damages are the results of anti-inflammatory, antibiotics and anti-cancer drugs as methotrexate [6,8,9]. 
Methotrexate (MTX) isa folic acid dihydrofolate reductase inhibitor used in the treatment of certain neoplastic, autoimmune 
and inflammatory diseases. A major side effects of its intake has highlighted the role of oxidative stress in causing toxicity 
on organs including the liver and kidney, due to the influx of methotrexate into the cell via active transport across the 
reduced folate carrier and its effluxes from the cell by ATP-binding cassette transporters [10,11]. An inhibition of both 
enzymatic and nonenzymatic antioxidants resulting in an increase of reactive oxygen species levels has been reported in 
the liver, kidney and other tissues of laboratory animals given methotrexate [13,14]. Toxic effect of MTX is related to a 
suppressive activity of folate metabolism include nodulosis, hepatic fibrosis, pulmonary fibrosis, lethargy, fatigue and renal 
failure [15]. Likewise, studies have reported the role of the adenosine pathway in methotrexate-induced hepatic fibrosis 
[16,17]. Some modern drugs have been developed to control these disturbances [6]. However, due to some side effects 
occurrence combined to the high cost of drugs, population in developing countries targeted medicinal plants to relieve their 
illness. Therefore, the urgent need to find out a hepatic-nephroprotective agent is mandatory for the safe use of this 
important drug. The use of plants to cure diseases is more frequent due to the efficiency and availability. Sorindeia 
julandifolia (Anacardiaceae) leaves are traditionally used for liver and kidney affection, but, no scientific evaluation has 
been done yet to demonstrate its activity. The aim of this study wasto evaluate the preventive effect of aqueous extract of 
Sorindeia juglandifolia leaves on methotrexate-induced liver and kidney damages in rat model. 
2. Methodology 
2.1. Extraction procedure and phytochemical analysis 
Sorindeia juglandifolia (twigs with leaves) was harvested in Kala Mountain in Yaoundé-Cameroon in October2011. Plant 
authentication was done by Mr. Mizili, a botanist at National Herbarium Yaoundé, in comparison with another specimen 
deposited in National Herbarium under number 1976 SRF Cam. The leaves were collected, air dried and pulverized. Nine 
hundred grams (900 g) of powder were decocted in 9.0 L of distilled water for one hour following the instructions of 
tradipractitionner healers, and then filtered with Wattman paper n°3. The filtrate was freeze-dried giving a crude extract of 
200 g with 22.22% of yield. Phytochemical analysis of extract was carried out using standard methodology described by 
Harborne, [18], Odebiyi & Sofowora, [19], Evans & Trease, [20], Sofowara, [21]. 
2.2. Experimental animals 
Ten weeks old males Wistar rats weighing about 150 g were used for experimentation. The animals were housed in sanitary 
cages, at room temperature (22 ± 2 °C) on a 12 h light-dark natural cycle in the animal house of the Faculty of Science of 
University of Yaoundé I, Cameroon. Food and water were given ad libitum during the experiment. The study protocol has 
been approved by Institutional Ethical Committee, which adopted all procedures recommended by the European Union on 
the protection of animals used for scientific proposes (CEE Council 86/609; Ref N° FWA-IRD 0001954). 
2.3. Study procedure 
The study was carried following the protocol of Chauhan et al [22] with slightly modification. Six groups of 5 healthy 
animals each were treated for 10 days with methotrexate Bellona® as followed: A neutral control group received distilled 
water (10 mL/kg), the methotrexate (MTX) control, treated with methotrexate (20 mg/kg) and the L-carnitin control 
receiving by sub-cutaneous route,,L-carnitin (500 mg/kg) followed two hours later by oral methotrexate (20 mg/kg). Three 
test groups were treated with aqueous extract of Sorindeia juglandifolia at the dose of 150, 250, 350 mg/kg, then, by 
methotrexate (20 mg/kg), two hours later. The different treatments were administered for ten days. During experiment, 
body weight was daily recorded. At the end of experimentation, the animals were fasted for 12 hours, sacrificed under 
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anesthesia with intraperitoneal injection of a combination of ketamin (30 mg/kg) and diazepam (10 mg/kg). Blood samples 
were then, collected for hematological and for biochemical analysis. Liver and kidney were carefully removed, weighted 
and a section (2 g) of each organ was crushed with 2 mL of TRIS buffer, homogenate was collected for oxidative parameters 
analysis. The remaining portion were fixed into 10 % buffered formalin for histopathological examination. 
2.4. Assessment of S. juglandifolia extract on biochemical analysis 
All biochemical parameters were performed according to standard protocols using Immesco kits (Germany). Serum 
biochemistry parameters included aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase 
(ALP), blood urea nitrogen (BUN), creatinine, bilirubin level, lipid profile (total cholesterol, HDL and LDL cholesterol, 
triglycerides), and some anti-oxidative parameters (glutathione (GSH), Superoxyde dismutase (SOD), catalase, 
Malonedialdehyde (MDA) and nitrites). 
2.5. Hematological parameters analysis 
Ethylene diamine tetra acetyl acid (EDTA) blood samples were used for hematological parameters assessment. Red blood 
cells count (RBC), Hemoglobin (HGB), hematocrit (HCT), total platelets count, white blood cells (WBC), percentage of 
lymphocytes, monocytes and granulocyte were determined. 
2.6. Histopathological analysis 
The liver and kidney of each animal fixed in 10 % buffered formalin were dehydrated with gradual concentrations of alcohol 
and then embedded in paraffin. Serial paraffin sections at 5 μm were stained with hematoxylin and eosin (HE) for 
examination under light microscopy brand Olympus and photography in objective 40 auricular 100 (HEx400). 
2.7. Statistical analysis  
The results were expressed as mean ± standard error of mean (SEM).The statistical analyses of data were performed using 
the Analysis of Variance, followed by the post test of Benferroni through GraphpadInstat software 5.03 version. Significant 
difference was considered for P < 0.05. 
3. Results 
3.1. Qualitative screening of the plant extract 
The aqueous extract of Sorindeia juglandifolia leaves revealed to contain metabolites such as polyoses, gallitannins, 
catecholamins tannins, phenolic component, saponins, anthraquinons, anthracenic, coumarins, fatty acid, alkaloids, 
flavonoids, terpenoides and sterols. 
3.2. Effects of aqueous extract of Sorindeia juglandifolia leaves on body weight and relative 
weight of organs 
The effects of extract on the body weight evolution of animal are shown in the Figure 1A. It was noted that daily 
administration of MTX to healthy animal for ten days resulted in a significant decrease (p < 0.001) of body weight in Mtx 
control compared to the neutral control.The treatment with extract at the dose of 250 and 350 mg/kg significantly prevented 
the decrease (p < 0.001) of body weight in comparison with the Mtx control. It was observed significant decrease of body 
weight (p < 0.001) of animal receiving the extract dose of 150 mg/kg from the day 6 (D6) to day 10 (D10), compared as 
well as to the neutral control, L-Carnitin control and dose extract (250 and 350 mg/kg). At the end of treatment, no 
significant change was observed in body weight of animals treated with extract (250 and 350 mg/kg) and L-Carnitin. 
MTX induced a significant increase in the relative weight of liver by 22.00% (p < 0.05) in MTX control compared to the 
neutral control (Figure 1B). Plant extract administration (150 mg/kg) prior methotrexate led to a significant increase in 
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relative weight of liver by 17.63% (p < 0.05) compared to the neutral control. The relative weight of kidneys was 













































































































Figure 1. Effects of aqueous extract of Sorindeia juglandifolia leaves on body weight evolution (A) and on the relative weight of liver and kidney 
(B).  
Values are expressed as mean ± SEM (n= 5), Neutral control = Healthy animals receiving distilled water, MTX control = 
animals receiving distilled water and methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) 
and methotrexate (20 mg/kg), S.jug. = animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 250 
mg/kg (S. jug 250 mg/kg) and 350 mg/kg (S.jug 350 mg/kg) followed to methotrexate administration. ≠p < 0.05, ≠≠p < 0.01, 
≠≠≠p < 0.001: significant difference compared to the neutral control, αp< 0.05, ααp < 0.01, αααp < 0.001: significant difference 
compared to the MTX control, *p < 0.05, **p < 0.01, ***p < 0.001: significant difference compared to the L-carnitin 
control. 
3.3. Effects of aqueous extract of Sorindeia juglandifolia leaves on some liver parameters.  
The Table 1 presents the effects of aqueous extract of Sorindeia juglandifolia leaves in liver of animals treated with 
methotrexate for 10 days. It appears that, daily administration of methotrexate resulted in a significant increase in 
transaminase activities by 40.78% (p < 0.05) and 37.21% (p < 0.01) in ALT and AST respectively, in total bilirubin by 
21.85 % (p < 0.05) and in serum protein levels by 30.18 % (p < 0.01) compared to the neutral control. A significant decrease 
in AST and ALT activities was observed in animal treated with the plant extract respectively by 42.60 % (p < 0.01) and 
22.13 % (p < 0.05)at the dose of 150 mg/kg, by 37.97 % and 40.83% (p < 0.01), at 250 mg/kg and by 39.54 % and 43.51% 
(p < 0.01) at 350 mg/kg compared to the MTX control. The L-carnitin administration induced significant decrease of ALT 
and AST activity by 40.92 % (p < 0.05), and 40.01% (p < 0.01), respectively. The treatment with the plant extract at the 
dose of 150 mg/kg and 250 mg/kg followed methotrexate, provoked a decrease in total bilirubin level by 16.17% (p < 0.05) 
and 27.76 % (p < 0.01) respectively, compared to the MTX control. Serum proteins level increased (p < 0.05) by 27.56%, 
29.61% and 27.65% at the respective dose extract of 250 mg/kg and 350 mg/kg and with L-carnitin (500 mg/kg). No 
significant change was observed in ALP activity in the experimental groups. 
Table 1. Effects of aqueous extract of Sorindeia juglandifolia on some serum parameters of liver function 
 ALT (UI/L) AST (UI/L) Bilirubin rate 
(mg/dL) 
ALP (UI/L) Serum proteins 
(mg/dL) 
Neutral control 174.56±13.48 257.60±16.29 8.75±1.09 125.25±18.20 0.56±0.01 
MTX control 294.77±14.95≠ 410.29±51.61≠≠ 11.19±0.80≠ 141.80±14.44 0.39±0.00≠≠ 
L-carnitin control 176.82±23.92α 242.36±35.01 αα 9.56±0.36 129.99±10.35 0.54±0.06α 
S.jug 150 mg/kg 229.52±27.72α 235.47±34.22αα 9.38±0.56α 127.00±4.25 0.49±0.01 
S.jug 250 mg/kg 174.39±26.01α 254.46±13.75 α 8.08±0.21αα 126.66±22.90 0.54±0.03α 
S.jug 350 mg/kg 166.50±31.50αα 248.05±21.33αα 10.14±0.14 123.97±10.91 0.56±0.03α 
Values are expressed as mean ± SEM, (n = 5). Neutral control = Healthy animals receiving distilled water, MTX control = 
animals receiving distilled water and methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) 
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and methotrexate (20 mg/kg), S.jug. = animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 250 
mg/kg (S. jug 250 mg/kg) and 350 mg/kg (S.jug 350 mg/kg) followed to methotrexate administration. ALT = alanine 
aminotransferase, AST = aspartate aminotransferase, APL = alkaline phosphate, ≠p < 0.05, ≠≠p < 0.01: significant difference 
compared to the neutral control, αp < 0.05, ααp < 0.01: significant difference compared to the MTX control. 
3.4. Effects of aqueous extract of Sorindeia juglandifolia leaves on lipid profile  
The effects of aqueous extract of Sorindeia juglandifolia leaves on lipid profile are summarized in Table 2. Ten days 
administration of MTX led to a significant increase in total cholesterol by 26.71%, (p < 0.05), LDL-cholesterol by 56.38% 
(p < 0.01), atherogen index by 25.99% (p < 0.05), and a significant decrease in HDL-cholesterol by 38.84% (p<0.001) 
compared to the neutral control. In comparison to MTX control, the plant extract significantly prevented the increase(p < 
0.05) of the total cholesterol level by 21.18%, 29.02% and 35.45% , the LDL-cholesterol concentration by 38.02%, 51.65% 
(p < 0.05) and 63.21% (p < 0.01), atherogen index by 41.81%, 58.63% and 61,34 %(p < 0.001) and the decrease of HDL-
cholesterol level by 24.58%, 40.01% and 38.22 % (p < 0.05) at the respective dose of 150, 250 and 150 mg/kg. L-carnitin 
injection induced significant decrease of total cholesterol by 29.32% (p < 0.05), LDL-cholesterol by 53.88% (p < 0.01) and 
atherogen index by 58.15% (p < 0.001) and rather the decrease of HDL-cholesterol by 24.58% (p < 0.05). A significant 
decrease in HDL-cholesterol (p < 0.05) and atherogen index (p < 0.05) was observed in animal treated with extract (150 
mg/kg) compared to L-carnitin control. No significant change was observed in triglycerides level in experimental groups. 
Table 2. Effects of aqueous extract of Sorindeia juglandifolia leaves on lipid profile 









Neutral control 62.41±2.70 28.04±2.30 23.98±0.45 51.92±4.54 2.61±0.15 
MTX control 85.16±2.32≠ 55.99±3.77≠≠ 14.66±1.13≠ 72.49±2.35 5.99±0.60≠≠ 
L-carnitin control 60.19±6.46α 25.82±6.5αα 24.12±0.50α 51.23±0.78 2.50±.0.29ααα 
S.jug 150 mg/kg 67.12±2.48α 34.70±2.42α 19.44±1.11≠α* 64.87±9.11 3.48±0.19≠ααα* 
S.jug 250 mg/kg 60.44±2.43α 27.07±4.70α 24.44±0.33α 44.61±10.58 2.47±0.12ααα 
S.jug 350 mg/kg 54.96±0.12α 20.60±1.38αα 23.73±0,11α 53.16±6.88 2.31±0.00ααα 
Values are expressed as mean ± SEM, (n= 5). Neutral control = Healthy animals receiving distilled water, MTX control = 
animals receiving distilled water and methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) 
and methotrexate (20 mg/kg), S.jug. = animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 250 
mg/kg (S. jug 250 mg/kg) and 350 mg/kg (S.jug 350 mg/kg) followed to methotrexate administration., ≠p < 0.5, ≠≠p < 0.01: 
significant difference compared to the neutral control,αp < 0.05, ααp < 0.01, αααp < 0.001: significant difference compared 
to the MTX control, *p < 0.05 : difference significant compared to the L-carnitin control. 
3.5. Effects of Sorindeia juglandifolia leaves extract on some serum parameters in kidney  
Table 3 shows that daily administration of methotrexate for ten days provoked a significant increase in serum urea level 
(70.85%,p < 0.01)and creatinine (72.23 %, p < 0.001), whereas, a significant decrease in serum sodium (43.37 %,p < 0.001) 
and in the glomerular filtration volume (84.72%,p< 0.001)was observed compared to the neutral control. Compared to the 
MTX control, treatment with plant extract prior to methotrexate administration induced a significant decrease in serum urea 
and creatinine concentration by 57.88% (p < 0.05) and 56.47 % (p < 0.01) at the dose of 250 mg/kg and by 50.49% and 
54.26% (p < 0.05) at the dose of 350 mg/kg, respectively. Treatment with L-carnitin has significantly decreased the serum 
urea and creatinine levels by 67.72 % and 56.79 % (p < 0.01) respectively. A significant increase in serum sodium 
concentration (p < 0.001) by 52.12%, 50.53%, 51.49 % and 51.91% was recorded with plant extract at the dose of 150 
mg/kg, 250 mg/kg and 350 mg/kg and with L-carnitin respectively, compared to the methotrexate control. It was observed 
a significant increase in the glomerular filtration by 47.66% (p < 0.001) at the dose extract of 250 mg/kg and L-carnitin.The 
extract at the dose of 150 mg/kg failed to prevent the increase in urea and creatinin concentration 
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Table 3. Effect of aqueous extract of Sorindeia juglandifolia on some serum parameters in kidney  
Values are expressed as mean ± SEM; (N = 5). Neutral control = Healthy animals receiving distilled water, MTX control 
= animals receiving distilled water and methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 
mg/kg) and methotrexate (20 mg/kg), S.jug. = animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 
250 mg/kg (S. jug 250 mg/kg) and 350 mg/kg (S.jug 350 mg/kg) followed to methotrexate administration. ≠p < 0.5, ≠≠p < 
0.01, ≠≠≠p < 0.001: significant difference compared to the neutral control, αp< 0.05, ααp < 0.01, αααp < 0.001: significant 
difference compared to the MTX control, *p < 0.05, **p < 0.01: difference significant compared to the L-carnitin control. 
3.6. Effects of the aqueous extract of Sorindeia juglandifolia leaves on some oxidative 
parameters 
Methotrexate administration to animals for ten days induced significant disturbance in oxidative stress parameters marked 
by a significant decrease in catalase activity by 27.41 %,(p < 0.01) in kidney, in glutathione concentration by 75.19% (p < 
0.001) and 88.43 %, in nitrites content by 22.61% and 24.88% (p < 0.001), in SOD activity by 20.95% and 17.37%, p < 
0.001) and in tissue proteins (p < 0.001) by 52.09% and 71.84% in liver and kidney respectively, compared to neutral 
control (Table 4). The methotrexate administration also provoked a significant increase in MDA concentration by 77.16% 
and 51.75% (p < 0.001) in liver and kidney respectively, in MTX control compared to the neutral control. In comparison 
with the MTX control, the plant extract significantly prevented the decrease in catalase activity by 27.43% and 18.12% (p 
< 0.001) at the dose of 150 mg/kg, also by 32.23% (p < 0.001) and 18.12% (p < 0.05) at 250 mg/kg in liver and kidney 
respectively, by 30.03% (p < 0.001) in liver at 350 mg/kg. L-carnitin induced significant increase in catalase activity (p < 
0.001) by 20.54% and in SOD by 21.08% (p < 0.05), in the liver of animals compared to the MTX control. 
A significant increase in glutathione concentration was observed with plant extract by 66.67% and 69.91% (p < 0.001) at 
the dose of 250 mg/kg, by 70.59% and 71.50 % (p < 0.001) at 350 mg/kg and by 71.27% and 66.73% (p < 0.001) with L-
carnitin in liver and kidney, respectively compared to MTX control.  
Nitrites level significantly increased with plant extract by 21.68 % (p < 0.001) in kidney at the dose of 250 mg/kg, 17.35% 
and 21.97% (p < 0.001) in liver and kidney, respectively in L-carnitin control compared to MTX control.  
In comparison to MTX control, total tissue proteins concentration increased in animals treated with plant extract by 45.67% 
and 38.46% (p < 0.01) at the dose 250 mg/kg, 48.33% and 56.65 % (p < 0.01) at 350 mg/kg and by 51.47 %, (p < 0.01) and 
70.99 % (p < 0.001) with L-carnitin in liver and kidney, respectively.  
The MDA level significantly decreased by 54.30%and 63.35 % (p < 0.001) at the extract dose of 150 mg/kg, 65.04% and 
63.04 % (p < 0.001) at 250 mg/kg, by 93.37% and 61.48 % (p < 0.001) at 350 mg/kg and by 73.90% and 47.95 % (p < 
0.001) with L-carnitin in the liver and kidney, respectively compared to MTX control. Compared to L-carnitin control, no 
significant change was observed in catalase, nitrites, SOD and MDA and plant extract whatever the dose. However, a 
significant decrease in glutathione level by 64.68% and 44.12 %, (p < 0.001) and in total proteins tissue by 32.78 %, (p < 
0.05) and 52.87 %, (p < 0.01) was noted in liver and kidney, respectively with extract at 150 mg/kg. 
Table 4. Effect of aqueous extract of Sorindeia juglandifolia on some oxidative stress parameters in liver and 
kidney tissues of animals. 








Neutral control 9.46±0.82 0.23±0.01 11.00± 0.24 301,81±16,83 3.10-2±0.00 
MTX control 32.46±1.35≠≠≠ 0.85±0.09≠≠≠ 10.67±0.23 169,67±13,34≠≠≠ 1.10-3±0.00≠≠≠ 
L-carnitin control 10.47±1.32αα 0.36±0.02αα 11.4±0.25 352,89±12,09ααα 2.10-2±0.00≠ααα 
S.jug 150 mg/kg 28.46±5.50≠≠≠* 0.58±0.02≠≠≠** 11.27±0.25 357,44±15,74ααα 1.10-2±0.00≠≠≠* 
S.jug 250 mg/kg 13.67±0.82α 0.37±0.02αα 10.91±0.22 346,01±9,10ααα 2.10-2±0.00≠≠≠αα 
S.jug 350 mg/kg 16.07±0.82α 0.38±0.04α 10.68±0.24 337,38±25,52ααα 1.10-2±0.00≠≠≠α 
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control 3.17±0.10 12.85±0.37 10.28±0.11 659.99±29.48 0.81±0.02 1.46±0.19 
MTX 
control 2.62±0.03 3.18±1.68≠≠≠ 8.13±0.12≠≠≠ 510.74±24.02≠≠≠ 0.39±0.02≠≠≠ 6.41±0.75≠≠≠ 
L-carnitin 3.30±0.11ααα 11.10±0.91ααα 10.30±0.13ααα 617.98±2.18αα 0.80±0.02αα 1.67±0.20ααα 
S.jug150 
 mg/kg 3.62±0.10ααα 3.92±0.17≠≠≠*** 8.91±0.11 546.33±26.42 0.54±0.02≠* 2.92±0.21ααα 
S.jug250 
 mg/kg 3.62±0.10ααα 3.92±0.17≠≠≠*** 8.91±0.11 546.33±26.42 0.54±0.02≠* 2.92±0.21ααα 
S.jug350  
mg/kg 3.75±0.11ααα 10.84±0.62ααα 9.98±0.11 531.05±36.57 0.75±0.02αα 0.42±0.04ααα 
Kidney 
Neutral 
control 3.39±0.54 29.95±1.74 8.22±0.21 635.53±29.48 0.50±0.02 2.80±0.34 
MTX 
control 2.46±0.02≠≠ 4.96±2.48≠≠≠ 6.79±0.13≠≠≠ 477.39±25.03≠≠≠ 0.14±0.02≠≠≠ 5.80±0.44≠≠≠ 
L-carnitin 2.81±0.08 14.91±1.49≠≠≠ααα 8.01±0.22 611.81±13.10ααα 0.49±0.09 ααα 3.02±0.77ααα 
S.jug150 
 mg/kg 3.00±0.09α 8.33±1.14≠≠≠*** 7.26±0.13 562.39±2.18 0.23±0.02≠≠* 2.12±0.45ααα 
S.jug250 
 mg/kg 3.00±0.13α 16.38±1.66≠≠≠ααα 7.70±0.11 609.58±24.02 0.46±0.14αα** 2.14±0.41ααα 
S.jug350  
mg/kg 2.87±0.07 17.41±1.53≠≠≠ααα 7.74±0.10 524.09±24.11 0.32±0.02≠ 2.23±0.45ααα 
Values are expressed as mean ± SEM (n= 5). Neutral control = Healthy animals receiving distilled water, MTX control = 
animals receiving distilled water and methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) 
and methotrexate (20 mg/kg), S.jug. = animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 250 
mg/kg (S. jug 250 mg/kg) and 350 mg/kg (S.jug 350 mg/kg) followed to methotrexate administration. ≠p < 0.05, ≠≠p < 0.01, 
≠≠≠p < 0.001: significant difference compared to the neutral control. αp < 0.05, ααp < 0.01, αααp < 0.001: significant difference 
compared to methotrexate control. *p < 0.05, **p < 0.001: difference significant compared to L-carnitin control. 
3.7. Effects of aqueous extract of Sorindeia juglandifolia leaves on hematological parameters  
The treatment with plant extract followed the methotrexate administration for 10 days do not significantly modify 
hematological parameters among experimental groups (Table 5).  
Table 5. Effects of aqueous extract of Sorindeia juglandifolia leaves on hematological parameters of animals 









S.jug250 mg/kg S.jug350 
mg/kg 
RBC (106/µL)  9.92±0.20 13.10±0.91 11.88±0.48 11.06±0.19 11.99±0.52 11.22±0.25 
Hemoglobin(g/dL) 9.70±1.60 10.14±1.64 9.00±1.23 8.20±0.95 10.64±1.82 9.50±1.41 
Hematocrit (%) 27.84±0.40 35.50±2.29 35.44±2.28 33.84±1.71 37.71±3.17 33.80±1.69 
Platelets (103/µL)  359.50±21.38 345.50±16.44 334.60±12.51 297.00±0.70 313.000±4.94 300.60±0.50 
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Values are expressed as mean ± SEM (N = 5). Neutral control = Healthy animals receiving distilled water, MTX control = 
animals receiving distilled water and methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) 
and methotrexate (20 mg/kg), S.jug. = animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 250 
mg/kg (S. jug 250 mg/kg) and 350 mg/kg (S.jug 350 mg/kg) followed to methotrexate administration. ≠≠≠≠p < 0.001: 
significant difference compared to the neutral control. 
3.8. Effects of Sorindeia juglandifolia leaves extract on the liver and kidney tissues in 
methotrexate-treated animals  
3.8.1. Effects of Sorindeia juglandifolia leaves extract on the liver tissues 
Figure 2 shows the effects of plant extract on liver of methotrexate-treated animals. The histology of the normal liver 
(Figure 2A) presents normal architecture with hepatocyte (H), portal vein (PV), bile canaliculi (BC) and hepatic artery 
(HA). Liver damage induced by methotrexate resulted in periportal fibrosis (PPF) and portal fibrosis (PF) (Figure 2B). 
Liver architecture of animal treated with plant extract whatever the dose (Figures 2C, 2D and 2E) or with L-carnitin (Figure 
2F) was similar to that of the neutral control, though the presence of sinusoidal dilatation (SD) observed in the parenchyma 
of animals treated with extract (350 mg/kg) and L-carnitin. 
 
Figure 2. Effects of Sorindeia juglandifolia leaves extraction on histological change in the liver tissue in neutral control (A), Methotrexate control 
(B), L-carnitin control (C), S.jug 150 mg/kg (D), S. jug 250 mg/kg (E), S. jug 350 mg/kg (F) (Hematoxylin-Eosine ×400). 
Neutral control = Healthy animals receiving distilled water, MTX control = animals receiving distilled water and 
methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) and methotrexate (20 mg/kg), S.jug. 
= animal treated with Sorindeia juglandifoliaat 150 mg/kg (S.jug 150 mg/kg), 250 mg/kg (S. jug 250 mg/kg) and 350 mg/kg 
(S.jug 350 mg/kg) followed to methotrexate administration. H=hepatocyte, PV = portal vein, CB = bile canaliculi, 
HA=hepatic artery, PPF=periportal fibrosis, PF=portal fibrosis, SD = sinusoidal dilatation. 
WBC (103/µL) 8.54±0.01 6.16±0.36 8.52±0.03 8.44±0.05 9.20±0.02 8.54±0.01 
Lymphocyte (%) 71.78±1.02 73.10±2.05 79.18±1.73 78.58±2.15 73.34±2.19 77.52±1.32 
Monocyte (%) 9.42±0.79 9.18±0.45 7.12±0.26 8.58±0.29 10.00±0.55 11.70±0.14 
Granulocyte (%) 11.82±0.62 10.32±0.15 6.48±0.53 7.12±0.28 9.62±0.22 7.13±0.21 
Wendja Nnouck Monique Alide et al. 
DOI: 10.31586/Hepatology.0401.01 135 Trends Journal of Sciences Research 
3.8.2. Effects of Sorindeia juglandifolia leaves extract on the kidney tissue 
The effects of S. juglandifolia extract on the histology of kidney tissue of animal treated with methotrexate are shown in 
the Figure 3. The kidney tissue of neutral control presents a normal architecture in kidney with proximal tube (PT), distal 
tube (DT), glomerular (G) and urine space (US) (Figure 3A). MTX induced some disorganization in kidney parenchyma, 
with glomerular fibrosis (GF), periglomerular fibrosis (PGF) and necrosis focus (Ne) in MTX control (Fig 3B). The plant 
extract administration prior methotrexate protected from damage showing normal architecture of kidney (Figure 3D, E and 
F) closed to the neutral control. Histology of kidney tissue of animals treated with L-carnitin showed normal architecture. 
 
Figure 3. Effects of Sorindeiajuglandifolia leaves extraction on histological change in the kidney tissuein neutral control (A), Methotrexate control 
(B), L-carnitin control(C), S.jug 150 mg/kg (D), S. jug 250 mg/kg (E), S. jug 350 mg/kg (F)(Hematoxylin-Eosine×400).  
Neutral control = Healthy animals receiving distilled water, MTX control = animals receiving distilled water and 
methotrexate 20 mg/kg; L-carnitin control = animals receiving L-carnitin (500 mg/kg) and methotrexate (20 mg/kg), S.jug. 
= animal treated with Sorindeia juglandifolia at 150 mg/kg (S.jug 150 mg/kg), 250 mg/kg (S. jug 250 mg/kg) and 350 
mg/kg (S.jug 350 mg/kg) followed to methotrexate administration.GF = glomerular fibrosis, PGF = periglomerular fibrosis, 
PT = proximal tube, DT = distal tube, G = glomerular, US = urine space, Ne = necrosis. 
4. Discussion 
The study aimed to investigate the effects of aqueous extract of Sorindeia juglandifolia leaves on methotrexate-induced 
liver and kidney damage. The methotrexate administration for ten days to healthy animal led to a decrease in body weight 
and an increase of relative weight of liver whereas that of kidney weight has decreased. These changes in MTX 
administration have been described as methotrexate side-effects with a high-dose therapy, resulting from the inhibition 
of dihydrofolate reductase (DHFR), an enzyme that implicates in the  tetrahydrofolate synthesis and  therefore, a prevention 
of synthesis of DNA, RNA, thymidylates, and proteins inducing a hypoproteinemia.[23,24] Likewise, methotrexate affects 
muscle mass and quality causing muscle wasting, which in turn could cause alterations in energy balance and the depletion 
of adipogenic precursors [25], justifying the loss of weight observed in the present study. 
The relative weight increase of liver might be due to the proliferation of collagen fibers that cause fibrosis in the parenchyma 
as observed in liver tissue of MTX control group. The consecutive administration of plant extract has prevented these 
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changes in animals, indicating the protective effects of plant. The plant activities could be due to the presence of phenol 
compounds as flavonoid, terpenoid that able to inhibit toxin effects and prevent the liver and kidneys impairment [26]. 
Besides, flavonoids component capture metallic ion involved in free radical’s production [27], inhibit enzymes activity 
involved in the production of cyclooxygenases, lipoxygenases and arachidonic acid, thereby inactive P-glycoprotein 
involved in the resistance of phenotypic cancer cells that can be issue to genetic mutation by drug [28]. 
The hypoproteinemia, the increase in serum alkaline phosphatase (ALP) level, total bilirubin level and transaminases 
(ALAT and ASAT) activities observed after MTX administration are conventional signs of liver failure. Indeed, 
methotrexate is an acid folic antagonist that blocks the synthesis of purines and pyrimidines by inhibiting of several key 
enzymes, resulting to its toxic effects that include liver damage by adenosine receptor pathway [17]. Methotrexate generates 
radical oxygen species that attack cells and damage their functions (membrane fluidity and membrane bound enzyme) as 
expressed in our study by the increase in MDA (a marker of lipid peroxidation); that lead to the leakage of these enzymes 
into the blood stream [29,30]. The preventive effect of plant extract to liver dysfunction could be assigned to phenol 
compound like tannins, capable to trap free radical agents and therefore protect hepatocytes from damage [31].  
The hypercholesterolemia, hypertriglyceridemia, the increase of the atherogen index and the decrease of HDL cholesterol 
observed after methotrexate administration for ten days sign of the occurrence of atherosclerosis development and coronary 
heart disease. This study is in concordance with those of Sabah and Yasmin [32] who reported that methotrexate induced 
an acid folic deficiency accompanied by increased risk of cardiovascular disease confirmed in the present study by lipid 
profile impairment. This dyslipidemia observed in the study also indicates liver injury and result in an imbalance between 
different types of cholesterol. Moreover, LDL cholesterol are more activated than HDL cholesterol because of the excessive 
lipolysis stimulation that generate fatty acids as alternative source of energy, that results in the fall of fatty acid stock into 
the liver [33]. This change was also observed into the liver tissue expressed by disorganization in the parenchyma. Sorindeia 
juglandifolia plant extract significantly reduced serum cholesterol, LDL-cholesterol and triglycerides and enhanced HDL-
cholesterol, suggesting its blood modulation properties in dyslipidemia and/ or it can prevent acid folic deficiency. The 
ability regulatory of plant extract could be due to the presence of flavonoid acting by increasing of cholesterol HDL and by 
reducing of total cholesterol [34]. These polyphenols act by inhibition of hyperlipidemia either by decrease in pancreatic 
lipase activity, inhibit triglyceride hydrolysis [35] or modify lipid metabolism that result in their excretion into stool [36]. 
The administration of methotrexate at the dose of 20 mg/kg provoked kidney damage characterized by an increase in serum 
urea and creatinine. It has been shown that, the increase in this parameter in serum indicate an alteration in glomerular 
filtration [37], as showed in this study. This alteration is also confirmed by the micro-architectural disorganization of the 
kidney. All of these physiological changes reflect a kidney failure, known as methotrexate toxic effects resulting from an 
obstructive nephropathy [22] with pre-glomerular vascular resistance disturbance [38], direct glomerular toxicity [39] or 
tubes toxicity [40]. These changes damage homeostasis control of calcium with the active vitamin D production [41] by 
acting on tubular calcic epithelial channel and on the edge brush of intestinal cells during calcium reabsorption [42]. 
Dysnatremia observed in the study is a sign of liver and kidney failure. The hepatic metabolism of methotrexate could cause 
fibrosis and progressive cirrhosis [43]. Fibrosis induces resistance of portal vein and cause its vasodilatation that result in 
blood retention in liver portal system. Vasodilatation due to nitrites [44] and prostaglandin [45] induce infiltration of water 
in abdomen and therefore, a decrease of blood stream in juxtaglomerular engine leading to the renin synthesis which 
stimulate angiotensin II production and emphasize vasoconstriction system in kidney. This change induces a decrease of 
capillary filtration surface and therefore a decrease of glomerular filtration [46] as observed in the study. Indeed, the 
systemic vasodilatation lead to a liver dysfunction involving carotid baroreceptors stimulation, which activates anti-
natriuretic system, especially the secretion of renin and angiotensin and stimulates the aldosterone hormone (ADH) 
synthesis, which induce water retention following by fibrosis or cirrhosis formation [47]. The plant extract has prevented 
kidney failure through the presence of flavonoid, tannins and coumarin components that act by preventing kidney 
abnormalities, suggesting the helpful activities of plant extract in the modulation of kidney function [48,49]. Flavonoids 
are known for their sodium homeostasis activing by Na+-K+-2Cl- cotransporter-1 (NKCC1) in epithelia’s cells which result 
into the Na+ reabsorption via the epithelial Na+ channel (ENaC) or via the epithelial Na+ channel (ENaC) inhibitory leading 
to the reduction of Na+ reabsorption and decrease of volume-dependent elevated blood pressure [50]. They also modulate 
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calcium homeostasis by acting on reticulum endoplasmic calcium-ATPase, responsible to the transport of calcium out or 
into the cells [51].  
It was observed a significant decrease in antioxidant defenses (SOD, nitric oxide (NO), glutathione, and catalase) in the 
liver and kidney of rats treated with methotrexate. These factors are implicated into the degradation of free radical’s species 
[52,53]. In fact, methotrexate treatment generates some reactive oxygen (ROS) and nitrogen (RNS) species, inhibits cytosol 
NADP-dependent dehydrogenase and NADP malic enzyme, which reduce the level of glutathione, superoxide dismutase, 
catalase and ultimately reducing the effectivity of the antioxidant defence system [54]. 
The prevention of antioxidant defence system decrease by plant extract suggesting its regulatory effects on oxidative stress. 
This antioxidant property could be targeted by flavonoids, coumarin, triterpene, tannins containing into the extract that 
induce cell protection and detoxification effects [30,55]. Tannins trap free radical agents and therefore protect cells from 
cell damage [30]. They are also protons donors to free radicals produced in lipid peroxidation to stop chain reaction of lipid 
oxidation [31]. Coumarin and its derivatives represent one of the most active classes of compound possessing a wide 
spectrum of biological role as anti-inflammatory activities [56]. Unsaturated terpen as sterols has vital role in cells structural 
integrity of organism by controlling ions permeability [57]. Polyphenol could act either by fixing electron to give stable 
radicals and thereby inhibits, decelerates or blocks oxidation chain reaction in cells [58]. 
5. Conclusion 
The present study demonstrated the preventive effect of aqueous extract leaves of Sorindeia juglandifolia on methotrexate-
induced liver and kidneys affections on Wistar rats. The plant extract has protected from liver damage by preventing the 
increase of transaminases activities alkaline phosphatase, total bilirubin, hypercholesterolemia and hypertriglyceridemia. 
Plant has also prevented to the kidney function impairment by modulating of creatinine, urea, protein and ions levels in 
serum and urine sample. The aqueous extract of Sorindeia juglandifolia leaves protected from metabolic disorders, 
oxidative stress and architectural disorganization observed into the organs (liver and kidneys). These results confirm the 
hepato-nephroprotective effects of Sorindeia juglandifolia and could justify its traditional use. 
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